At the time of writing, Fractyl Health Inc [GUTS] stock is trading at $1.55, down -1.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GUTS shares have gain 15.67% over the last week, with a monthly amount glided 72.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fractyl Health Inc [NASDAQ: GUTS] stock has seen the most recent analyst activity on September 15, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on August 28, 2025, and set its price target to $3.60. On February 28, 2024, Evercore ISI initiated with a Outperform rating. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $18 on February 27, 2024. BofA Securities initiated its recommendation with a Buy and recommended $26 as its price target on February 27, 2024.
For the past year, the stock price of Fractyl Health Inc fluctuated between $0.82 and $3.48. Fractyl Health Inc [NASDAQ: GUTS] shares were valued at $1.55 at the most recent close of the market.
Analyzing the GUTS fundamentals
According to Fractyl Health Inc [NASDAQ:GUTS], the company’s sales were 0.02M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at -32.35% with Operating Profit Margin at -5873.06%, Pretax Profit Margin comes in at -5868.65%, and Net Profit Margin reading is -5868.65%. To continue investigating profitability, this company’s Return on Assets is posted at -1.61, Equity is -5.96 and Total Capital is -2.49. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -3.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4733 points at the first support level, and at 1.3967 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5883, and for the 2nd resistance point, it is at 1.6267.
Ratios To Look Out For
It is important to note that Fractyl Health Inc [NASDAQ:GUTS] has a current ratio of 1.22. Further, the Quick Ratio stands at 1.22, while the Cash Ratio is 1.02. Considering the valuation of this stock, the price to sales ratio is 10245.00.
Transactions by insiders
Recent insider trading involved Royan Ajay, Director, that happened on Mar 14 ’25 when 17901.0 shares were purchased. Director, Barnes Kelly Ann completed a deal on Mar 14 ’25 to buy 31000.0 shares. Meanwhile, Director SCHULMAN AMY W bought 8550.0 shares on Mar 13 ’25.
